Reveal Pharmaceuticals Inc.
2 clinical trials · Sponsor
◉ Watch Reveal Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent (NCT06322342) | Reveal Pharmaceuticals Inc. | 2024-08-15 |
| First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent (NCT05413668) | Reveal Pharmaceuticals Inc. | 2022-05-18 |
Track Reveal Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.